Revenue
2020
2021
2022
2023
2024
2025
Bolt Biotherapeutics, Inc. (BOLT)
Price$3.94Cached quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $7.7M | $7.7M | $7.9M | $5.7M | $1.3M | $231,000 |
| Research & development | $28.5M | $57.5M | $61.5M | $73.1M | $75.7M | $40.4M |
| Operating expenses | $43.8M | $80.7M | $84.1M | $96.0M | $94.0M | $49.4M |
| Operating income | −$36.1M | −$73.0M | −$76.2M | −$90.3M | −$92.8M | −$49.2M |
| Operating margin | −469.30% | −949.91% | −967.45% | −1,576.56% | −7,364.13% | −21,290.91% |
| EBITDA | −$34.8M | −$71.3M | −$74.3M | −$88.7M | −$91.6M | −$48.6M |
| EBITDA margin | −452.53% | −926.75% | −943.91% | −1,547.48% | −7,269.44% | −21,026.41% |
| Net income | −$33.4M | −$63.1M | −$69.2M | −$88.1M | −$98.6M | −$60.7M |
| Net profit margin | −433.74% | −820.78% | −878.58% | −1,537.76% | −7,824.68% | −26,289.18% |
| Basic EPSper basic share | -$17.85 | -$33.06 | -$1.83 | -$2.36 | -$2.97 | -$28.89 |
| Diluted EPSper diluted share | -$17.85 | -$33.06 | -$1.83 | -$2.36 | -$2.97 | -$28.89 |
Owners
Reported shareholders
7.15%of listed shares
Sofinnova Investments, Inc.137.72K shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Sofinnova Investments, Inc. | 7.15%137.72K shares |
RENAISSANCE TECHNOLOGIES LLC | 5.12%98.63K shares |
Vivo Capital, LLC | 3.76%72.41K shares |
CITADEL ADVISORS LLC | 2.95%56.9K shares |
Yonehiro Grant | ≈2.02%38.92K shares |
T3 Companies, LLC | 1.97%38K shares |
Board of Trustees of The Leland Stanford Junior University | 1.87%35.98K shares |
Pfizer Inc | 1.63%31.31K shares |
Lynx1 Capital Management LP | 1.60%30.8K shares |
NANO CAP NEW MILLENNIUM GROWTH FUND L P | 1.43%27.5K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.99%19.12K shares |
Shay Capital LLC | 0.80%15.44K shares |
BlackRock, Inc. | 0.50%9.71K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.37%7.06K shares |
Nan Fung Group Holdings Ltd | 0.26%5K shares |
MORGAN STANLEY | 0.16%3.15K shares |
VANGUARD FIDUCIARY TRUST CO | 0.16%3.1K shares |
NewEdge Advisors, LLC | 0.13%2.53K shares |
Quinn William P. | ≈0.12%2.31K shares |
Tower Research Capital LLC (TRC) | 0.09%1.71K shares |
Percentages use 1.93M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 5, 2025Form 4 | Quinn William P.President, CEO and CFO | BuyCommon Stock | 125 | $4.61 | $576.25 | 2.3K |
| Dec 5, 2025Form 4 | Nemec SarahSenior VP, Finance and PAO | BuyCommon Stock | 125 | $4.61 | $576.25 | 1.4K |
| Jun 6, 2025Form 4 | Nemec SarahSenior VP, Finance and PAO | BuyCommon Stock | 125 | $5.49 | $686.25 | 943 |
| Jun 6, 2025Form 4 | Quinn William P.President, CEO and CFO | BuyCommon Stock | 125 | $5.49 | $686.25 | 2.2K |
| Dec 16, 2024Form 4 | Nemec SarahSenior VP, Finance and PAO | BuyCommon Stock | 2.5K | $0.50 | $1.3K | 16.6K |